INNOVATE & CURE
Dedicated to developing cutting-edge therapeutic antibodies, REMUUN is committed to transforming healthcare and saving lives.
Meet The Team
Prof Dr Richard Chahwan
Founder & iCEO
With a latest stint as head of the Cancer Immunobiology Lab - University of Zurich and with degrees from the University of Toronto & University of Cambridge, I bring innovative ideas, interdisciplinary experience, and rigor to REMUUN.
Romina Fetti, MBA
CFO / CBO
As an economist and business specialist with over 30+ years of experience I support REMUUN in all aspects finance and business development.
Paulina Wyrzykowska
VP Research
As a scientist with 20+ years of research experience I support REMUUN in all aspects involving biochemical, molecular, and cellular needs.
OUR INNOVATIVE BIOTECH PLATFORM
MEGA
At REMUUN, we strive to revolutionize the biotech industry with our advanced MEGA therapeutic antibody development platform. Founded by Prof. Dr. Richard Chahwan, we are dedicated to creating therapeutic monoclonal antibodies 50x faster and more effectively.
This will drive the future of medicine, enhance patient care, and improve global health outcomes